Answers are grounded in this paper and cite their sources.
The calmodulin (CaM) implicates in the pathological process of Cerebral ischemia-reperfusion injury (CIRI) remains unclear. This study aims to explore the role of CaM in oxidative stress injury during CIRI. The correlation analysis between plasma CaM and cerebral infarction of ischemic stroke patients was conducted. In vivo and in vitro models were established to simulate ischemic stroke. Gene function was validated by transfection with CaM- or myosin light-chain kinase (MLCK)-specific siRNA or via luciferase activity experiments. Protein-protein interactions were investigated via bioinformatics analysis and co-immunoprecipitation assays. Protein expression levels, intracellular calcium and reactive oxygen species (ROS) levels were detected.Plasma CaM levels positively correlated with infarct size in ischemic stroke patients. In in vivo or in vitro model, the expression of CaM, MLCK, NADPH oxidase 2/4 (NOX2/4) and cytochrome c (cyt-c) increased, accompanied by calcium overload and ROS overproduction. Bioinformatics analysis reveals interactions among CaM, MLCK, NOX2, and NOX4. CaM or MLCK knockdown significantly downregulates the expression of CaM, MLCK, NOX2/4, and cyt-c in MCAO rats and H/R-treated SH-SY5Y cells, as well as ROS. However, CaM knockdown not significantly decrease intracellular Ca²⁺ and MLCK knockdown has no effect on CaM expression. CaM or MLCK siRNA can significantly reduce the luciferase activity of SH-SY5Y cells transfected with MLCK-P plasmid, or NOX2-P or NOX4-P plasmids.Our findings demonstrate that CaM promotes oxidative stress in CIRI via the CaM/MLCK/NOX2/NOX4 axis, indicating that CaM acts upstream of MLCK and has potential as a therapeutic target for ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: